
B4T offers a non-invasive bioplatform that aims to rejuvenate cells for healthier ageing and fertility. It uses mRNA, AI, and nanotechnology to target genetic-level cellular rejuvenation. Core tech includes AI-driven analysis, mRNA-based interventions, and nanoscale delivery. Category is B2B biotech platform serving research, clinical, and pharma partners; integrates with laboratory workflows. The market aims at scalable therapies for aging and fertility with broad potential impact.

B4T offers a non-invasive bioplatform that aims to rejuvenate cells for healthier ageing and fertility. It uses mRNA, AI, and nanotechnology to target genetic-level cellular rejuvenation. Core tech includes AI-driven analysis, mRNA-based interventions, and nanoscale delivery. Category is B2B biotech platform serving research, clinical, and pharma partners; integrates with laboratory workflows. The market aims at scalable therapies for aging and fertility with broad potential impact.